SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements



BEIJING — Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (the “Notification Letter”), from Hearing Advisor of The Nasdaq Stock Market LLC., indicating that the Company has regained compliance with Listing Rule 5250(c)(1) and that the Company is therefore in compliance with the Nasdaq Global Market’s listing requirements. As noted in the Hearing Panel’s May 20, 2026 compliance determination, the Company remains under a Mandatory Panel Monitor pursuant to Listing Rule 5815(d)(4)(B) until May 20, 2027. Read More



Source link

  • Related Posts

    How Fed Chairman Kevin Warsh just screwed AI tech beasts

    Big Tech had it good under former Fed Chair Jerome Powell. He overcommunicated the Fed’s next moves. He popped up in intrameeting interviews. And most importantly, he didn’t do anything…

    Lamb shank, 48 cans of beans, gum: A look at what Alberta’s politicians expense

    The Alberta Legislature is seen in Edmonton, Thursday, Oct. 31, 2024. THE CANADIAN PRESS/Jason Franson – The Canadian Press · The Canadian Press EDMONTON — A survey of spending over…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Nigerian woman dodges deportation due to fears of being made a mistress

    George W. Bush gifts Michelle Obama a tin of Altoids at Obama Center opening in an ode to their friendship

    George W. Bush gifts Michelle Obama a tin of Altoids at Obama Center opening in an ode to their friendship

    How Fed Chairman Kevin Warsh just screwed AI tech beasts

    How Fed Chairman Kevin Warsh just screwed AI tech beasts

    Quebec town recognizes the rights of trees

    Quebec town recognizes the rights of trees

    Malware Has Gotten Smarter. Here’s How Your Antivirus Has, Too

    Malware Has Gotten Smarter. Here’s How Your Antivirus Has, Too

    The Sunday Papers | Rock Paper Shotgun

    The Sunday Papers | Rock Paper Shotgun